ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,973, issued on April 14, was assigned to Parr Biotechnology (Hebei) Co. Ltd. (Shijiazhuang City, China).
"CpG ODN having immunoregulatory function and use thereof" was invented by Ligong Wang (Shijiazhuang City, China) and Yan Shao (Shijiazhuang City, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an immunomodulatory CpG ODN chemically modified by means of a structure as shown by general formula I and the use thereof. The CpG ODN has an immunostimulatory activity, can stimulate the proliferation of B cells, and produce specific cytokines. The above-mentioned CpG ODN can be used as a vaccine adjuvant alone or in combination with o...